What is Trajenta 5Mg Tablet?
trajenta 5Mg Tablet is a dipeptidyl peptidase-4 inhibitor. It is used for the treatment of type 2 diabetes. It is a type of antidiabetic medication used in case proper diet and exercise alone is not sufficient to control and curb diabetes. Trajenta 5Mg Tablet works by stimulating increase in the insulin secretion and decrease in sugar produced by your body.
If you have type 1 diabetes, have diabetic ketoacidiosis (high levels of blood ketone), or if you are allergic to Trajenta 5Mg Tablet or any ingredient in it then you should refrain from using it. You should consult you doctor first, before using Trajenta 5Mg Tablet if you are pregnant, plan on becoming pregnant, breastfeeding, have history of pancreatitis or angioedema, or if you are taking any medicines, supplements or herbal preparations.There are latest trajenta 5mg price available at online.
Uses of Trajenta 5 mg Tablet
What is it prescribed for?
Type II Diabetes Mellitus
Trajenta 5 mg Tablet use reduces blood glucose levels in patients with type II diabetes mellitus.
In addition to its intended effect, Trajenta 5Mg Tablet side effects too. In such cases, you must seek medical attention immediately. This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.
- Hypoglycaemia (Low blood sugar level) in combination with insulin or sulphonylurea
Take the missed linagliptin dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Seek emergency medical treatment or contact the doctor in case of an overdose.
Warnings for special population
Pregnancy – Tradjenta 5 mg generic is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
breast-feeding – Linagliptin is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
Insulin secreagogues – Tradjenta 5 mg uses with caution in patients who are using insulin secretagogues due to the increased risk of hypoglycemia. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition.
Bullous pemphigoid – Tradjenta 5 mg tablet should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
Arthralgia – Tradjenta 5 mg tab should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient’s condition. Close monitoring of patient’s condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.